NationalunP2
The successful candidate will work in the laboratory of Dr. Alexander Vinogradov at NUS on developing late-stage peptide modification strategies and utilizing them for drug discovery applications. The project focuses on creating mRNA display-compatible peptide cyclization and modification strategies to discover cyclic peptides targeting proteins with high therapeutic potential. The role involves designing and conducting experiments in bio-organic chemistry and chemical biology, analyzing data, and preparing research findings for publication.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NationalunP2.
NationalunP2 didn’t post a salary, so this is our estimate from similar listings.
11% above the average for this role